Growth Metrics

Apellis Pharmaceuticals (APLS) Debt Ratio (2024 - 2025)

Apellis Pharmaceuticals filings provide 2 years of Debt Ratio readings, the most recent being 0.42 for Q4 2025.

  • For the quarter ending Q4 2025, Debt Ratio rose 4.25% year-over-year to 0.42, compared with a TTM value of 0.42 through Dec 2025, up 4.25%, and an annual FY2025 reading of 0.42, up 4.25% over the prior year.
  • Debt Ratio hit 0.42 in Q4 2025 for Apellis Pharmaceuticals, down from 0.43 in the prior quarter.
  • The five-year high for Debt Ratio was 0.45 in Q1 2025, with the low at 0.4 in Q3 2024.